Study on Clinical Features and Outcomes of Breast Sarcoma

Condition(s) studied

Investigational drug(s) / intervention(s)

Treatment of Breast Sarcoma according clinical practice (includes drugs, surgery or any other received treatments): This observational study collects all the treatments received by the patients according clinical practices or experimental trials and therefore includes drug/biological/surgical and any other applicable treatments Reorder Outcome Measures

Study summary

This is multi-institutional retrospective study in order to identify the most relevant clinical characteristics, treatment strategies, to explore the impact on principal clinical outcomes and finally, to suggest some principles for management and treatment of breast sarcomas.

The study will collect data about patients affected by breast sarcoma referred to participating Institutions between January 2000 and June 2020

Eligibility

Primary outcome measure(s)

• Treatments received for breast sarcoma — At diagnosis (baseline) and after 6, 12, 18, 24, 36, 48 and 60 weeks
  To describe treatment that patient diagnosed with breast sarcoma, received
• Number of patients with primary breast sarcoma — Through study inclusion period, an average of 20 years
  Number of patient with a diagnosis of primary breast sarcoma

Trial sites (14)

More Italian Sarcoma Group trials in Italy